EDAP is the global leader in the area of medical
devices based on High Intensity Focused Ultrasound (HIFU).
EDAP is an international company headquartered
in Lyon, France. The company is entirely dedicated to the HIFU
technology
for the minimally invasive treatment of localized cancer. The EDAP
Research & Development team works closely together with French
Medical Research Institutes in order to test the feasibility
and
efficacy of new minimally invasive treatment methods. The Clinical
Studies are conducted internationally and so is the Marketing
of
the medical devices.
Due to the unique cooperation between research teams,
doctors and the company, the cutting edge medical devices marketed
by EDAP are developed to respond to patients' as well as doctors'
needs. The results are minimally invasive treatments that minimize
side effects and thus allow for rapid recovery of the patient.
Conclusive results from the clinical studies led
over the past ten years show that EDAP is today the most advanced
company in therapeutic ultrasound.The
Ablatherm, a HIFU device for the treatment of localized prostate
cancer, is the first HIFU device to have obtained the CE mark
in 2000.
EDAP THE HIFU COMPANY also develops the Focalized
Ultrasound technique for the treatment of other cancer pathologies.
Due to large investments in Research & Development, EDAP ensures
its capacity to maintain its position as pioneer in the area of
therapeutic ultrasound. The strong distribution network reinforces
the leadership position of EDAP in the area of High Intensity
Focused
Ultrasound.
EDAP SA is an EDAP
TMS company. Listed on the US NASDAQ National Market System,
the Group develops, manufactures and distributes a portfolio of
minimally invasive medical devices mainly for the treatment of urological
diseases.